Kuros Biosciences AG (CSBTF)

Market Cap	1.08B +28.2%
Revenue (ttm)	146.06M +71.5%
Net Income	2.55M
EPS	0.06
Shares Out	n/a
PE Ratio	421.45
Forward PE	86.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	353
Average Volume	628
Open	28.40
Previous Close	29.00
Day's Range	28.40 - 28.40
52-Week Range	19.44 - 42.81
Beta	0.63
RSI	36.73
Earnings Date	Mar 10, 2026

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or posterolateral spine; and Attrax, a biphasic calcium phosphate bone graft...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 178
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSBTF